首页 > 最新文献

European journal of obstetrics, gynecology, and reproductive biology最新文献

英文 中文
The impact of total laparoscopic excision of deep endometriosis (DE) on bladder and bowel dysfunction: a prospective longitudinal study 腹腔镜下深度子宫内膜异位症(DE)全切除术对膀胱和肠功能障碍的影响:一项前瞻性纵向研究
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-20 Epub Date: 2025-12-29 DOI: 10.1016/j.ejogrb.2025.114924
James S. Morris , Smita Rajshekhar , Giulia Gremmo , Katie Keane , Saikat Banerjee
Deep endometriosis (DE) is established to cause chronic pelvic pain (CPP), lower urinary tract symptoms (LUTS) and altered bowel function. Although the aim of surgical excision is often to relieve CPP, evidence suggests it could also affect LUTS and bowel symptoms, especially where DE affects the bowel or urinary tract. We assessed the prevalence and improvements in CPP, LUTS and bowel symptoms in 130 patients preoperatively and 6 months following total excision of endometriosis using the British Society for Gynaecological Endoscopy (BSGE) Pelvic Pain Questionnaire. Pain symptoms and LUTS are graded 0–10 whilst bowel function is scored 0–4, each using Likert scales. Patients with urinary tract DE reported median bladder pain and bladder voiding dysfunction of 7/10 (95 % CI: 3–8) and 7/10 (95 % CI: 0–9), respectively. Improvements at follow-up did not reach statistical significance at the Šidák-adjusted significance threshold, although 80.0 % and 60.0 % of patients reported clinically important improvements to these respective symptoms. There were also no cases of de novo LUTS following excision of urinary tract DE. Patients with bowel DE reported CPP and menstrual dyschezia of 7/10 (95 % CI: 6–8) and 8/10 (95 % CI: 4–8), respectively. Although a significant proportion of patients with bowel DE reported clinically important improvements in bowel symptoms, the difference in symptomatic severity failed to reach statistical significance. Whilst excision of DE can produce clinically important improvements in LUTS and bowel symptoms in a large proportion of patients, there is also a considerable risk of occasioning de novo bowel symptoms.
深子宫内膜异位症(DE)可引起慢性盆腔疼痛(CPP)、下尿路症状(LUTS)和肠功能改变。虽然手术切除的目的通常是缓解CPP,但有证据表明,它也可能影响LUTS和肠道症状,特别是DE影响肠道或泌尿道。我们使用英国妇科内镜学会(BSGE)盆腔疼痛问卷评估了130例患者术前和子宫内膜异位症全切除术后6个月的CPP、LUTS和肠道症状的患病率和改善情况。疼痛症状和LUTS评分为0-10分,肠道功能评分为0-4分,均采用李克特量表。尿路DE患者报告中位膀胱疼痛和膀胱排尿功能障碍分别为7/10 (95% CI: 3-8)和7/10 (95% CI: 0-9)。尽管80.0%和60.0%的患者报告这些症状在临床上有重要的改善,但随访时的改善在Šidák-adjusted显著性阈值下没有达到统计学意义。在尿路de切除术后也没有新发LUTS病例。肠de患者报告的CPP和月经障碍分别为7/10 (95% CI: 6-8)和8/10 (95% CI: 4-8)。虽然有相当比例的肠DE患者报告了临床上重要的肠道症状改善,但症状严重程度的差异未达到统计学意义。虽然切除DE可以在临床上对很大一部分患者的LUTS和肠道症状产生重要的改善,但也有相当大的风险引起肠道新症状。
{"title":"The impact of total laparoscopic excision of deep endometriosis (DE) on bladder and bowel dysfunction: a prospective longitudinal study","authors":"James S. Morris ,&nbsp;Smita Rajshekhar ,&nbsp;Giulia Gremmo ,&nbsp;Katie Keane ,&nbsp;Saikat Banerjee","doi":"10.1016/j.ejogrb.2025.114924","DOIUrl":"10.1016/j.ejogrb.2025.114924","url":null,"abstract":"<div><div>Deep endometriosis (DE) is established to cause chronic pelvic pain (CPP), lower urinary tract symptoms (LUTS) and altered bowel function. Although the aim of surgical excision is often to relieve CPP, evidence suggests it could also affect LUTS and bowel symptoms, especially where DE affects the bowel or urinary tract. We assessed the prevalence and improvements in CPP, LUTS and bowel symptoms in 130 patients preoperatively and 6 months following total excision of endometriosis using the British Society for Gynaecological Endoscopy (BSGE) Pelvic Pain Questionnaire. Pain symptoms and LUTS are graded 0–10 whilst bowel function is scored 0–4, each using Likert scales. Patients with urinary tract DE reported median bladder pain and bladder voiding dysfunction of 7/10 (95 % CI: 3–8) and 7/10 (95 % CI: 0–9), respectively. Improvements at follow-up did not reach statistical significance at the Šidák-adjusted significance threshold, although 80.0 % and 60.0 % of patients reported clinically important improvements to these respective symptoms. There were also no cases of <em>de novo</em> LUTS following excision of urinary tract DE. Patients with bowel DE reported CPP and menstrual dyschezia of 7/10 (95 % CI: 6–8) and 8/10 (95 % CI: 4–8), respectively. Although a significant proportion of patients with bowel DE reported clinically important improvements in bowel symptoms, the difference in symptomatic severity failed to reach statistical significance. Whilst excision of DE can produce clinically important improvements in LUTS and bowel symptoms in a large proportion of patients, there is also a considerable risk of occasioning <em>de novo</em> bowel symptoms.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114924"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145881264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of mediolateral or lateral episiotomy in preventing obstetric anal sphincter injury (OASI) in nulliparous women undergoing vacuum-assisted delivery: A systematic review and meta-analysis 中外侧或外阴切开术在预防无产妇女接受真空辅助分娩时产科肛门括约肌损伤(OASI)中的作用:一项系统回顾和荟萃分析
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-20 Epub Date: 2026-01-05 DOI: 10.1016/j.ejogrb.2026.114939
Giovanni Morganelli , Gabriella Maria Celora , Maria Chiara Bassi , Andrea Dall’Asta , Maurizio Di Serio , Vito Andrea Capozzi , Tullio Ghi , Stefania Fieni

Background

The potential preventive effect of mediolateral and lateral episiotomy on the risk of anal sphincter injury related to vacuum delivery in nullipara has been reported by different well-designed studies in the last years.

Objectives

The aim of this systematic review and meta-analysis is to summarize the available evidence on the protective effect of mediolateral or lateral episiotomy towards the occurrence of obstetric anal sphincter injury (OASI) in nulliparous women who were submitted to vacuum-assisted delivery.
Search strategy: PubMed, Embase, CINAHL, Cochrane Library and Scopus databases were retrospectively searched without any temporal restriction up to March 1st 2025.
Selection criteria: Randomized controlled trials, retrospective, prospective case-control or cohort studies investigating the incidence of perineal tears involving anal sphincter muscles and/or rectal mucosa after vacuum-assisted birth with and without mediolateral/lateral episiotomy in nulliparous women were included.
Data collection and analysis: Risk of bias assessment was conducted for each included study by applying ROB2 score for RCTs and ROBINS-I score for non-randomized studies. Data were extracted and analyzed with Review Manager 5.4.1, results were reported by means of pooled Odd-ratios (ORs) and presented as Forest plots.
Main results: 31 studies (3 RCTs and 28 non-randomized studies) were included. Cumulative sample size consisted in 608,359 nulliparous women who were submitted to vacuum-assisted delivery. Mediolateral/lateral episiotomy was found to halve the incidence of OASI (OR 0.56 [95 % CI 0.42–0.73]) with high between-study heterogeneity reported (I2 = 99 %). At sensitivity analysis, a significant reduction in OASI incidence in case of mediolateral/lateral episiotomy was confirmed (OR 0.58 [95 %CI 0.44–0.78]); this analysis was conducted on low/moderate risk of bias studies (1RCT e 5 non-randomized studies, 15,799 patients) and associated with low heterogeneity (I2 = 42 %).

Conclusions

This updated meta-analysis on the role of mediolateral/lateral episiotomy in nulliparous women submitted to vacuum assisted delivery confirms its protective role from OASI.
背景:在过去的几年里,不同的精心设计的研究已经报道了外阴中外侧切开术对肛门括约肌损伤风险的潜在预防作用。目的:本系统回顾和荟萃分析的目的是总结关于真空辅助分娩的未产妇女中外阴切开或外阴切开对产科肛门括约肌损伤(OASI)发生的保护作用的现有证据。检索策略:回顾性检索PubMed, Embase, CINAHL, Cochrane Library和Scopus数据库,无任何时间限制,截止到2025年3月1日。选择标准:包括随机对照试验、回顾性、前瞻性病例对照或队列研究,这些研究调查了无产妇女在有或没有外阴中外侧切开术的真空辅助分娩后涉及肛门括约肌和/或直肠粘膜的会阴撕裂的发生率。资料收集与分析:随机对照试验采用ROB2评分,非随机试验采用ROBINS-I评分,对每项纳入的研究进行偏倚风险评估。采用Review Manager 5.4.1软件对数据进行提取和分析,结果以混合奇比(or)报告,并以Forest样地表示。主要结果:纳入31项研究(3项rct和28项非随机研究)。累积样本量包括608359名接受真空辅助分娩的无产妇女。发现外阴内外侧切开术使OASI的发生率减少一半(OR 0.56 [95% CI 0.42-0.73]),研究间异质性较高(I2 = 99%)。在敏感性分析中,证实外阴中外侧切开术的OASI发生率显著降低(OR 0.58 [95% CI 0.44-0.78]);本分析是在低/中等偏倚风险研究(1RCT和5个非随机研究,15799例患者)中进行的,并且与低异质性相关(I2 = 42%)。结论:这一最新的荟萃分析证实了真空辅助分娩的无产妇女中外阴中外侧切开术的保护作用。
{"title":"Role of mediolateral or lateral episiotomy in preventing obstetric anal sphincter injury (OASI) in nulliparous women undergoing vacuum-assisted delivery: A systematic review and meta-analysis","authors":"Giovanni Morganelli ,&nbsp;Gabriella Maria Celora ,&nbsp;Maria Chiara Bassi ,&nbsp;Andrea Dall’Asta ,&nbsp;Maurizio Di Serio ,&nbsp;Vito Andrea Capozzi ,&nbsp;Tullio Ghi ,&nbsp;Stefania Fieni","doi":"10.1016/j.ejogrb.2026.114939","DOIUrl":"10.1016/j.ejogrb.2026.114939","url":null,"abstract":"<div><h3>Background</h3><div>The potential preventive effect of mediolateral and lateral episiotomy on the risk of anal sphincter injury related to vacuum delivery in nullipara has been reported by different well-designed studies in the last years.</div></div><div><h3>Objectives</h3><div>The aim of this systematic review and <em>meta</em>-analysis is to summarize the available evidence on the protective effect of mediolateral or lateral episiotomy towards the occurrence of obstetric anal sphincter injury (OASI) in nulliparous women who were submitted to vacuum-assisted delivery.</div><div><em>Search strategy:</em> PubMed, Embase, CINAHL, Cochrane Library and Scopus databases were retrospectively searched without any temporal restriction up to March 1st 2025.</div><div><em>Selection criteria:</em> Randomized controlled trials, retrospective, prospective case-control or cohort studies investigating the incidence of perineal tears involving anal sphincter muscles and/or rectal mucosa after vacuum-assisted birth with and without mediolateral/lateral episiotomy in nulliparous women were included.</div><div><em>Data collection and analysis:</em> Risk of bias assessment was conducted for each included study by applying ROB2 score for RCTs and ROBINS-I score for non-randomized studies. Data were extracted and analyzed with Review Manager 5.4.1, results were reported by means of pooled Odd-ratios (ORs) and presented as Forest plots.</div><div><em>Main results:</em> 31 studies (3 RCTs and 28 non-randomized studies) were included. Cumulative sample size consisted in 608,359 nulliparous women who were submitted to vacuum-assisted delivery. Mediolateral/lateral episiotomy was found to halve the incidence of OASI (OR 0.56 [95 % CI 0.42–0.73]) with high between-study heterogeneity reported (I<sup>2</sup> = 99 %). At sensitivity analysis, a significant reduction in OASI incidence in case of mediolateral/lateral episiotomy was confirmed (OR 0.58 [95 %CI 0.44–0.78]); this analysis was conducted on low/moderate risk of bias studies (1RCT e 5 non-randomized studies, 15,799 patients) and associated with low heterogeneity (I<sup>2</sup> = 42 %).</div></div><div><h3>Conclusions</h3><div>This updated meta-analysis on the role of mediolateral/lateral episiotomy in nulliparous women submitted to vacuum assisted delivery confirms its protective role from OASI.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114939"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145922007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expectant management of tubal ectopic pregnancy: Updated decision tree analysis for the prediction of successful outcomes 输卵管异位妊娠的预期治疗:预测成功结果的最新决策树分析
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-20 Epub Date: 2026-01-14 DOI: 10.1016/j.ejogrb.2026.114966
Natasha Graham , Sanem Atakan , Jemma Johns , Jackie A. Ross

Objectives

To re-analyse and update a decision tree developed 20 years ago to counsel women regarding the likelihood of successful expectant management of tubal ectopic pregnancies. The original model was developed using the data from 179 cases.

Study design

A retrospective observational analysis spanning a 14-year period was undertaken at the early pregnancy unit of an inner-city teaching hospital. Data were collected for all women who had expectant management when first diagnosed with their tubal ectopic pregnancies. Initial serum human chorionic gonadotropin (hCG) and progesterone levels, gestational age, ectopic morphology and mean diameter of the ectopic were recorded. Data were analysed using decision tree analysis on SPSS (IBM).

Results

A total of 798/1968 (40.5%) women with tubal ectopic pregnancies had expectant management and a new decision tree was developed using data from these 798 cases. Expectant management was successful in 512/798. This was 64% of women embarking on expectant management and 26% of all women with tubal ectopic pregnancies. Initial serum hCG level remains the best predictor of success for expectant management. Combined with progesterone level and diameter measurement, the decision tree has been updated.

Conclusion

Biochemical and clinical markers can be used to help counsel women about the likelihood of successful expectant management in our early pregnancy unit using decision tree analysis.
目的重新分析和更新20年前制定的决策树,为输卵管异位妊娠成功的可能性提供建议。最初的模型是利用179个病例的数据开发的。研究设计:在市中心一家教学医院的早孕病房进行了为期14年的回顾性观察分析。收集所有首次诊断为输卵管异位妊娠的妇女的数据。记录初始血清人绒毛膜促性腺激素(hCG)和孕酮水平、胎龄、异位形态和异位平均直径。数据分析采用SPSS (IBM)的决策树分析。结果798/1968例(40.5%)输卵管异位妊娠患者采用了准治疗,并建立了新的决策树。准管理在512/798年是成功的。在所有输卵管异位妊娠的女性中,这一比例为64%,占26%。初始血清hCG水平仍然是预期治疗成功的最佳预测指标。结合孕激素水平和直径测量,更新了决策树。结论采用决策树分析方法,利用生化指标和临床指标,可帮助指导早孕妇女成功进行妊娠管理的可能性。
{"title":"Expectant management of tubal ectopic pregnancy: Updated decision tree analysis for the prediction of successful outcomes","authors":"Natasha Graham ,&nbsp;Sanem Atakan ,&nbsp;Jemma Johns ,&nbsp;Jackie A. Ross","doi":"10.1016/j.ejogrb.2026.114966","DOIUrl":"10.1016/j.ejogrb.2026.114966","url":null,"abstract":"<div><h3>Objectives</h3><div>To re-analyse and update a decision tree developed 20 years ago to counsel women regarding the likelihood of successful expectant management of tubal ectopic pregnancies. The original model was developed using the data from 179 cases.</div></div><div><h3>Study design</h3><div>A retrospective observational analysis spanning a 14-year period was undertaken at the early pregnancy unit of an inner-city teaching hospital. Data were collected for all women who had expectant management when first diagnosed with their tubal ectopic pregnancies. Initial serum human chorionic gonadotropin (hCG) and progesterone levels, gestational age, ectopic morphology and mean diameter of the ectopic were recorded. Data were analysed using decision tree analysis on SPSS (IBM).</div></div><div><h3>Results</h3><div>A total of 798/1968 (40.5%) women with tubal ectopic pregnancies had expectant management and a new decision tree was developed using data from these 798 cases. Expectant management was successful in 512/798. This was 64% of women embarking on expectant management and 26% of all women with tubal ectopic pregnancies. Initial serum hCG level remains the best predictor of success for expectant management. Combined with progesterone level and diameter measurement, the decision tree has been updated.</div></div><div><h3>Conclusion</h3><div>Biochemical and clinical markers can be used to help counsel women about the likelihood of successful expectant management in our early pregnancy unit using decision tree analysis.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114966"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145973385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-hormonal vaginal gel improves vaginal and sexual health in menopausal women: results from a 6-month prospective study. 非激素阴道凝胶改善更年期妇女阴道和性健康:一项为期6个月的前瞻性研究的结果。
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-20 Epub Date: 2025-12-19 DOI: 10.1016/j.ejogrb.2025.114902
Luigi Della Corte , Mario Palumbo , Antonisia Pollio , Ilenia Nobile , Lara Cuomo , Giuseppe Bifulco

Introduction

Genitourinary syndrome of menopause (GSM) is a prevalent, progressive condition affecting more than half of postmenopausal women, often compromising vaginal and sexual health. While local estrogen therapy remains the mainstay of treatment, non-hormonal alternatives are increasingly required, particularly for women with contraindications to hormonal therapy.

Study design

To evaluate the efficacy and safety of a non-hormonal, Aloe-vera-based vaginal gel enriched with cellulose derivatives and plant extract and sugar complex in improving vaginal health and sexual function in postmenopausal women, as assessed by changes in vaginal pH, Vaginal Health Index (VHI), and Female Sexual Function Index (FSFI) over a six-month period. In this prospective observational study, 52 postmenopausal women were evaluated at baseline, 3 months, and 6 months. Vaginal pH was measured clinically, while the VHI and FSFI were assessed using instruments with established evidence of validity and reliability. Friedman and Wilcoxon tests were applied for within-subject comparisons, and linear mixed-effects models were fitted to evaluate the impact of time, age, and BMI.

Results

All parameters significantly improved over time (p < 0.0001). Mean vaginal pH decreased from 5.51 ± 0.39 at baseline to 4.75 ± 0.33 at 6 months, indicating partial restoration of vaginal acidity. VHI increased by + 5.89 ± 2.34 points, and FSFI improved by + 6.80 ± 3.15. At 6 months, 40.4 % of participants achieved FSFI scores ≥ 26.55. Linear mixed models confirmed time as a significant predictor, while age and BMI had no significant effect. No adverse events were reported.

Conclusions

Aloe-vera-based non-hormonal vaginal gel therapy significantly improved vaginal health and sexual function in postmenopausal women, independently of age and BMI. The formulation’s moisturizing, soothing, and protective properties likely underlie these benefits, offering a safe and effective non-hormonal option for the management of GSM.
绝经期泌尿生殖系统综合征(GSM)是一种普遍的进行性疾病,影响超过一半的绝经后妇女,经常损害阴道和性健康。虽然局部雌激素治疗仍然是主要的治疗方法,但越来越需要非激素替代疗法,特别是对有激素治疗禁忌症的妇女。研究设计:通过六个月期间阴道pH值、阴道健康指数(VHI)和女性性功能指数(FSFI)的变化来评估一种非激素的芦荟阴道凝胶(富含纤维素衍生物、植物提取物和糖复合物)改善绝经后妇女阴道健康和性功能的有效性和安全性。在这项前瞻性观察性研究中,52名绝经后妇女在基线、3个月和6个月时进行了评估。临床测量阴道pH值,而VHI和FSFI则使用具有既定有效性和可靠性证据的仪器进行评估。采用Friedman和Wilcoxon检验进行受试者内比较,并拟合线性混合效应模型来评估时间、年龄和BMI的影响。结论:以芦荟为基础的无激素阴道凝胶治疗可显著改善绝经后妇女的阴道健康和性功能,与年龄和BMI无关。该配方的保湿、舒缓和保护特性可能是这些益处的基础,为GSM的管理提供了安全有效的非激素选择。
{"title":"Non-hormonal vaginal gel improves vaginal and sexual health in menopausal women: results from a 6-month prospective study.","authors":"Luigi Della Corte ,&nbsp;Mario Palumbo ,&nbsp;Antonisia Pollio ,&nbsp;Ilenia Nobile ,&nbsp;Lara Cuomo ,&nbsp;Giuseppe Bifulco","doi":"10.1016/j.ejogrb.2025.114902","DOIUrl":"10.1016/j.ejogrb.2025.114902","url":null,"abstract":"<div><h3>Introduction</h3><div>Genitourinary syndrome of menopause (GSM) is a prevalent, progressive condition affecting more than half of postmenopausal women, often compromising vaginal and sexual health. While local estrogen therapy remains the mainstay of treatment, non-hormonal alternatives are increasingly required, particularly for women with contraindications to hormonal therapy.</div></div><div><h3>Study design</h3><div>To evaluate the efficacy and safety of a non-hormonal, Aloe-vera-based vaginal gel enriched with cellulose derivatives and plant extract and sugar complex in improving vaginal health and sexual function in postmenopausal women, as assessed by changes in vaginal pH, Vaginal Health Index (VHI), and Female Sexual Function Index (FSFI) over a six-month period. In this prospective observational study, 52 postmenopausal women were evaluated at baseline, 3 months, and 6 months. Vaginal pH was measured clinically, while the VHI and FSFI were assessed using instruments with established evidence of validity and reliability. Friedman and Wilcoxon tests were applied for within-subject comparisons, and linear mixed-effects models were fitted to evaluate the impact of time, age, and BMI.</div></div><div><h3>Results</h3><div>All parameters significantly improved over time (p &lt; 0.0001). Mean vaginal pH decreased from 5.51 ± 0.39 at baseline to 4.75 ± 0.33 at 6 months, indicating partial restoration of vaginal acidity. VHI increased by + 5.89 ± 2.34 points, and FSFI improved by + 6.80 ± 3.15. At 6 months, 40.4 % of participants achieved FSFI scores ≥ 26.55. Linear mixed models confirmed time as a significant predictor, while age and BMI had no significant effect. No adverse events were reported.</div></div><div><h3>Conclusions</h3><div>Aloe-vera-based non-hormonal vaginal gel therapy significantly improved vaginal health and sexual function in postmenopausal women, independently of age and BMI. The formulation’s moisturizing, soothing, and protective properties likely underlie these benefits, offering a safe and effective non-hormonal option for the management of GSM.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114902"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145833471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of maternal characteristics and outcomes associated with COVID-19-linked HELLP-like syndrome 评估与covid -19相关的help样综合征相关的孕产妇特征和结局
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-20 Epub Date: 2026-01-12 DOI: 10.1016/j.ejogrb.2026.114959
Lucy F. Harvey , Fay F. Pon , Zaira N. Chavez Jimenez , Yadira L. Bribiesca Leon , Carolyn N. Rocha , Shinya Matsuzaki , Rachel S. Mandelbaum , Joseph G. Ouzounian , Koji Matsuo
{"title":"Assessment of maternal characteristics and outcomes associated with COVID-19-linked HELLP-like syndrome","authors":"Lucy F. Harvey ,&nbsp;Fay F. Pon ,&nbsp;Zaira N. Chavez Jimenez ,&nbsp;Yadira L. Bribiesca Leon ,&nbsp;Carolyn N. Rocha ,&nbsp;Shinya Matsuzaki ,&nbsp;Rachel S. Mandelbaum ,&nbsp;Joseph G. Ouzounian ,&nbsp;Koji Matsuo","doi":"10.1016/j.ejogrb.2026.114959","DOIUrl":"10.1016/j.ejogrb.2026.114959","url":null,"abstract":"","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114959"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145973292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developmental kinetics distinguish meiotic from mitotic chromosomal defects: Day-5 blastocyst achievement as age-independent predictor of euploid embryo yield 发育动力学区分减数分裂和有丝分裂染色体缺陷:第5天囊胚成就作为整倍体胚胎产量的年龄无关预测因子
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-20 Epub Date: 2026-01-02 DOI: 10.1016/j.ejogrb.2026.114935
Mai Vuong Hung , Pham Thi Hai Ha , Nguyen Khac Han Hoan , Nguyen Thanh Luan

Background

While maternal age is established as a dominant reproductive risk factor, the mechanistic distinction between age-dependent meiotic errors and age-independent mitotic errors remains uncharacterized. These divergent pathways have profound implications for patient counseling and treatment stratification but are rarely differentiated clinically.

Objectives

To establish distinct etiological pathways underlying chromosomal abnormalities by quantifying the differential age-sensitivity of whole-chromosome aneuploidies (meiotic origin) versus mosaic abnormalities (mitotic origin), determining whether developmental timing serves as an age-independent biomarker of genomic competence, and enabling practitioners to provide pathway-specific counseling and treatment recommendations.

Search strategy

PubMed, Embase, and ClinicalTrials.gov were searched for relevant studies.

Selection criteria

Retrospective cohort of 490 IVF patients (2,472 embryos) stratified by maternal age (≤35, 35–40, ≥40 years) with complete extended culture and next-generation sequencing (NGS)-based preimplantation genetic testing for aneuploidy.

Data collection and analysis

Age-stratified analysis of developmental kinetics and comprehensive chromosomal classification. Multivariate logistic regression identified independent predictors of aneuploidy, adjusting for maternal age and day-5 blastocyst count.

Main results

Whole-chromosome aneuploidies demonstrated striking age-sensitivity (14.0 % to 36.5 %, 2.6-fold increase, p < 0.001), reflecting progressive cohesin complex degradation, spindle checkpoint decline, and mitochondrial bioenergetic insufficiency. Mosaicism remained age-independent (∼41 %, p = 0.383), arising from post-meiotic mitotic errors. Day-5 blastocyst formation declined 30 % with age (p = 0.0154), yet day-6 formation remained age-independent (p = 0.106), indicating developmental delay rather than failure. Day-5 blastocyst count independently protected against aneuploidy (OR 0.965, 95 % CI: 0.944–0.987, p = 0.002), persisting after multivariate adjustment.

Conclusions

Mechanistic differentiation between age-dependent meiotic and age-independent mitotic chromosomal abnormalities reveals fundamentally distinct etiological pathways with profound implications for clinical decision-making. In particular, day-5 blastocyst achievement emerges as an independent biomarker of oocyte quality, enabling precise within-age-group risk stratification regardless of chronological age. These findings translate developmental kinetics into quantitative clinical algorithms that substantially improve reproductive counseling accuracy and patient-specific prognostication beyond traditional age-based approaches.
虽然母亲年龄被确定为主要的生殖风险因素,但年龄依赖性减数分裂错误和年龄依赖性有丝分裂错误之间的机制区别仍未明确。这些不同的途径对患者的咨询和治疗分层有着深远的影响,但在临床上很少被区分。目的通过量化全染色体非整倍体(减数分裂起源)与mosaic异常(有丝分裂起源)的年龄敏感性差异,确定发育时间是否作为基因组能力的年龄独立生物标志物,并使从业者能够提供特定途径的咨询和治疗建议,从而建立染色体异常的独特病因学途径。检索pubmed、Embase和ClinicalTrials.gov等相关研究。选择标准:对490例体外受精患者(2472个胚胎)进行回顾性队列研究,按母亲年龄(≤35岁、35 - 40岁、≥40岁)分层,进行完全扩展培养和基于下一代测序(NGS)的非整倍体植入前基因检测。数据收集和分析发育动力学的分层分析和全面的染色体分类。多因素logistic回归确定了非整倍体的独立预测因素,调整了母亲年龄和第5天囊胚计数。主要结果全染色体非整倍体表现出显著的年龄敏感性(14.0% ~ 36.5%,增加2.6倍,p < 0.001),反映出黏结蛋白复合物的逐渐降解、纺锤体检查点下降和线粒体生物能量不足。镶嵌现象与年龄无关(~ 41%,p = 0.383),由减数分裂后的有丝分裂错误引起。第5天囊胚形成随年龄增长下降30% (p = 0.0154),而第6天囊胚形成与年龄无关(p = 0.106),表明发育迟缓而非发育失败。第5天囊胚计数独立保护非整倍体(OR 0.965, 95% CI: 0.944-0.987, p = 0.002),在多因素调整后持续存在。结论年龄依赖性减数分裂和年龄依赖性有丝分裂染色体异常的机制差异揭示了根本不同的病因途径,对临床决策具有重要意义。特别是,第5天囊胚发育成为卵母细胞质量的独立生物标志物,无论实际年龄如何,都可以精确地进行年龄组内风险分层。这些发现将发育动力学转化为定量临床算法,大大提高了生殖咨询的准确性和患者特异性预测,超越了传统的基于年龄的方法。
{"title":"Developmental kinetics distinguish meiotic from mitotic chromosomal defects: Day-5 blastocyst achievement as age-independent predictor of euploid embryo yield","authors":"Mai Vuong Hung ,&nbsp;Pham Thi Hai Ha ,&nbsp;Nguyen Khac Han Hoan ,&nbsp;Nguyen Thanh Luan","doi":"10.1016/j.ejogrb.2026.114935","DOIUrl":"10.1016/j.ejogrb.2026.114935","url":null,"abstract":"<div><h3>Background</h3><div>While maternal age is established as a dominant reproductive risk factor, the mechanistic distinction between age-dependent meiotic errors and age-independent mitotic errors remains uncharacterized. These divergent pathways have profound implications for patient counseling and treatment stratification but are rarely differentiated clinically.</div></div><div><h3>Objectives</h3><div>To establish distinct etiological pathways underlying chromosomal abnormalities by quantifying the differential age-sensitivity of whole-chromosome aneuploidies (meiotic origin) versus mosaic abnormalities (mitotic origin), determining whether developmental timing serves as an age-independent biomarker of genomic competence, and enabling practitioners to provide pathway-specific counseling and treatment recommendations.</div></div><div><h3>Search strategy</h3><div>PubMed, Embase, and ClinicalTrials.gov were searched for relevant studies.</div></div><div><h3>Selection criteria</h3><div>Retrospective cohort of 490 IVF patients (2,472 embryos) stratified by maternal age (≤35, 35–40, ≥40 years) with complete extended culture and next-generation sequencing (NGS)-based preimplantation genetic testing for aneuploidy.</div></div><div><h3>Data collection and analysis</h3><div>Age-stratified analysis of developmental kinetics and comprehensive chromosomal classification. Multivariate logistic regression identified independent predictors of aneuploidy, adjusting for maternal age and day-5 blastocyst count.</div></div><div><h3>Main results</h3><div>Whole-chromosome aneuploidies demonstrated striking age-sensitivity (14.0 % to 36.5 %, 2.6-fold increase, p &lt; 0.001), reflecting progressive cohesin complex degradation, spindle checkpoint decline, and mitochondrial bioenergetic insufficiency. Mosaicism remained age-independent (∼41 %, p = 0.383), arising from post-meiotic mitotic errors. Day-5 blastocyst formation declined 30 % with age (p = 0.0154), yet day-6 formation remained age-independent (p = 0.106), indicating developmental delay rather than failure. Day-5 blastocyst count independently protected against aneuploidy (OR 0.965, 95 % CI: 0.944–0.987, p = 0.002), persisting after multivariate adjustment.</div></div><div><h3>Conclusions</h3><div>Mechanistic differentiation between age-dependent meiotic and age-independent mitotic chromosomal abnormalities reveals fundamentally distinct etiological pathways with profound implications for clinical decision-making. In particular, day-5 blastocyst achievement emerges as an independent biomarker of oocyte quality, enabling precise within-age-group risk stratification regardless of chronological age. These findings translate developmental kinetics into quantitative clinical algorithms that substantially improve reproductive counseling accuracy and patient-specific prognostication beyond traditional age-based approaches.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114935"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145922008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study of the ovarian function and gyneco-obstetrical profile of patients with an HNF1B abnormality HNF1B异常患者卵巢功能及妇产科概况的研究
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-20 Epub Date: 2026-01-14 DOI: 10.1016/j.ejogrb.2026.114961
Audrey Cartault , Camille Paret , Charlotte Garczynski , Sabrina Da Costa , Zeina Chakhtoura , Perrine Ernoult , Dominique Chauveau , Stéphane Decramer , Stanislas Faguer , Magali Viaud , Céline Mercier , Vanessa Rousseau , Claire Thalamas , Nicolas Gatimel , Catherine Pienkowski

Objective

HNF1B variant is a rare autosomal dominant disease that affects the embryonic development of the urogenital system, the mullerian development, the liver, the exocrine and endocrine pancreas functions responsible for MODY 5 diabetes. The objective of this study was to evaluate the ovarian reserve and the gyneco-obstetric profile of patients with an HNF1B anomaly.

Study design

This was a pilot study coordinated by the Reference Centre of Rare Gynecological Pathologies (RGP). It was conducted in 3 hospital sites after agreement of the Reference Centres of Rare Renal Diseases. The primary endpoint was the serum AMH concentration, the secondary endpoint was the gyneco-obstetric characteristics of the patients.

Results

26 of the 54 patients aged 29 ± 13 years agreed to participate. All are carriers of the HNF1 pathogenic variant with a deletion in 50% of cases. 38% of patients had an AMH level <25th percentile adjusted for age. No statistical significant association was observed with genetic, renal abnormality, or Mody diabetes. Their gynecological profile was comparable to general population. 42% had uterine malformation. Obstetric complications of threatened premature delivery, cholestasis of pregnancy were noted.

Conclusions

We have, for the first time, described the ovarian function and gyneco-obstetric profile of patients with an HNF1 variant. We highlighted the value of monitoring their ovarian reserve. Fertility preservation should be discussed on an individual basis. These data need to be confirmed by a larger study and a longitudinal follow up.
目的hnf1b变异体是一种罕见的常染色体显性遗传病,影响胚胎发育的泌尿生殖系统,苗勒管发育,肝脏,外分泌和内分泌胰腺功能负责mody5型糖尿病。本研究的目的是评估卵巢储备和HNF1B异常患者的妇产科概况。研究设计这是一项由罕见妇科病理参考中心(RGP)协调的试点研究。经罕见肾脏疾病参考中心同意后,在3家医院进行了检查。主要终点是血清AMH浓度,次要终点是患者的妇产科特征。结果54例患者(29±13岁)中26例同意参与。所有人都是HNF1致病变异的携带者,50%的病例有缺失。38%的患者有AMH水平<;年龄调整后的第25百分位。未观察到与遗传、肾脏异常或糖尿病有统计学意义的关联。他们的妇科概况与一般人群相当。42%有子宫畸形。产科并发症的先兆早产,胆汁淤积妊娠注意。结论:我们首次描述了HNF1变异患者的卵巢功能和妇产科特征。我们强调了监测卵巢储备的价值。保留生育能力应在个人基础上进行讨论。这些数据需要通过更大规模的研究和纵向随访来证实。
{"title":"Study of the ovarian function and gyneco-obstetrical profile of patients with an HNF1B abnormality","authors":"Audrey Cartault ,&nbsp;Camille Paret ,&nbsp;Charlotte Garczynski ,&nbsp;Sabrina Da Costa ,&nbsp;Zeina Chakhtoura ,&nbsp;Perrine Ernoult ,&nbsp;Dominique Chauveau ,&nbsp;Stéphane Decramer ,&nbsp;Stanislas Faguer ,&nbsp;Magali Viaud ,&nbsp;Céline Mercier ,&nbsp;Vanessa Rousseau ,&nbsp;Claire Thalamas ,&nbsp;Nicolas Gatimel ,&nbsp;Catherine Pienkowski","doi":"10.1016/j.ejogrb.2026.114961","DOIUrl":"10.1016/j.ejogrb.2026.114961","url":null,"abstract":"<div><h3>Objective</h3><div>HNF1B variant is a rare autosomal dominant disease that affects the embryonic development of the urogenital system, the mullerian development, the liver, the exocrine and endocrine pancreas functions responsible for MODY 5 diabetes. The objective of this study was to evaluate the ovarian reserve and the gyneco-obstetric profile of patients with an HNF1B anomaly.</div></div><div><h3>Study design</h3><div>This was a pilot study coordinated by the Reference Centre of Rare Gynecological Pathologies (RGP). It was conducted in 3 hospital sites after agreement of the Reference Centres of Rare Renal Diseases. The primary endpoint was the serum AMH concentration, the secondary endpoint was the gyneco-obstetric characteristics of the patients.</div></div><div><h3>Results</h3><div>26 of the 54 patients aged 29 ± 13 years agreed to participate. All are carriers of the HNF1 pathogenic variant with a deletion in 50% of cases. 38% of patients had an AMH level &lt;25th percentile adjusted for age. No statistical significant association was observed with genetic, renal abnormality, or Mody diabetes. Their gynecological profile was comparable to general population. 42% had uterine malformation. Obstetric complications of threatened premature delivery, cholestasis of pregnancy were noted.</div></div><div><h3>Conclusions</h3><div>We have, for the first time, described the ovarian function and gyneco-obstetric profile of patients with an HNF1 variant. We highlighted the value of monitoring their ovarian reserve. Fertility preservation should be discussed on an individual basis. These data need to be confirmed by a larger study and a longitudinal follow up.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114961"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146022741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Value of triglyceride-glucose index in diagnosis of gestational diabetes mellitus: a systematic review and meta-analysis 甘油三酯-葡萄糖指数在妊娠期糖尿病诊断中的价值:系统回顾和荟萃分析
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-20 Epub Date: 2025-12-31 DOI: 10.1016/j.ejogrb.2025.114931
Binze Chen , Teng Ma , Ying Liu , Mengting Wang , Tingting Yin , Yanxia Han

Purpose

To assess the accuracy of triglyceride-glucose index (TyG) in the diagnosis of gestational diabetes mellitus (GDM).

Methods

Embase, Cochrane Library, PubMed, and Web of Science were searched up to April 18, 2025 for English-language clinical studies using TyG for GDM prediction. The Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool was utilized for quality assessment, and the final results were presented by RevMan5.3. The overall accuracy of TyG in GDM diagnosis was identified using Stata15.0 and Meta-DiSc1.4. We also performed subgroup analyses by the sample size, prevalence, cutoff, and trimester of pregnancy.

Results

Sixteen studies with 480,402 participants were included. The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio of TyG in GDM diagnosis were 0.63 (95 % CI 0.56–0.70), 0.64 (95 % CI 0.60–0.68), 1.80 (95 % CI 1.60–1.90), 0.57 (95 % CI 0.49–0.67), and 3.00 (95 % CI 2.00–4.00), respectively. The area under the summary receiver operating characteristic (SROC) curve of TyG was 0.68 (95 % CI 0.64–0.72). Subgroup analyses revealed that small sample sizes, high prevalence, cutoff < 8.5, and the second trimester corresponded to the high accuracy of TyG in GDM diagnosis.

Conclusion

TyG demonstrates moderate diagnostic accuracy for GDM, with an area under the SROC curve of 0.68. Considering the limitations of the available studies, more prospective studies are still required to clarify the diagnostic value of TyG in actual clinical practice and offer a stronger basis for clinical decision-making.
目的探讨甘油三酯-葡萄糖指数(TyG)在妊娠期糖尿病(GDM)诊断中的准确性。方法检索sembase、Cochrane Library、PubMed和Web of Science,检索截至2025年4月18日使用TyG预测GDM的英文临床研究。采用诊断准确性研究质量评估-2 (QUADAS-2)工具进行质量评估,最终结果由RevMan5.3给出。使用Stata15.0和Meta-DiSc1.4确定TyG在GDM诊断中的总体准确性。我们还根据样本量、患病率、截止时间和妊娠三个月进行了亚组分析。结果共纳入16项研究,480402名受试者。TyG在GDM诊断中的敏感性、特异性、阳性似然比、阴性似然比、诊断优势比分别为0.63 (95% CI 0.56 ~ 0.70)、0.64 (95% CI 0.60 ~ 0.68)、1.80 (95% CI 1.60 ~ 1.90)、0.57 (95% CI 0.49 ~ 0.67)、3.00 (95% CI 2.00 ~ 4.00)。TyG的综合受试者工作特征(SROC)曲线下面积为0.68 (95% CI 0.64 ~ 0.72)。亚组分析显示,样本量小、患病率高、临界值<; 8.5、妊娠中期与TyG在GDM诊断中的准确性较高相对应。结论tyg对GDM的诊断准确率中等,SROC曲线下面积为0.68。考虑到现有研究的局限性,仍需要更多的前瞻性研究来明确TyG在实际临床中的诊断价值,为临床决策提供更有力的依据。
{"title":"Value of triglyceride-glucose index in diagnosis of gestational diabetes mellitus: a systematic review and meta-analysis","authors":"Binze Chen ,&nbsp;Teng Ma ,&nbsp;Ying Liu ,&nbsp;Mengting Wang ,&nbsp;Tingting Yin ,&nbsp;Yanxia Han","doi":"10.1016/j.ejogrb.2025.114931","DOIUrl":"10.1016/j.ejogrb.2025.114931","url":null,"abstract":"<div><h3>Purpose</h3><div>To assess the accuracy of triglyceride-glucose index (TyG) in the diagnosis of gestational diabetes mellitus (GDM).</div></div><div><h3>Methods</h3><div>Embase, Cochrane Library, PubMed, and Web of Science were searched up to April 18, 2025 for English-language clinical studies using TyG for GDM prediction. The Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool was utilized for quality assessment, and the final results were presented by RevMan5.3. The overall accuracy of TyG in GDM diagnosis was identified using Stata15.0 and Meta-DiSc1.4. We also performed subgroup analyses by the sample size, prevalence, cutoff, and trimester of pregnancy.</div></div><div><h3>Results</h3><div>Sixteen studies with 480,402 participants were included. The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio of TyG in GDM diagnosis were 0.63 (95 % CI 0.56–0.70), 0.64 (95 % CI 0.60–0.68), 1.80 (95 % CI 1.60–1.90), 0.57 (95 % CI 0.49–0.67), and 3.00 (95 % CI 2.00–4.00), respectively. The area under the summary receiver operating characteristic (SROC) curve of TyG was 0.68 (95 % CI 0.64–0.72). Subgroup analyses revealed that small sample sizes, high prevalence, cutoff &lt; 8.5, and the second trimester corresponded to the high accuracy of TyG in GDM diagnosis.</div></div><div><h3>Conclusion</h3><div>TyG demonstrates moderate diagnostic accuracy for GDM, with an area under the SROC curve of 0.68. Considering the limitations of the available studies, more prospective studies are still required to clarify the diagnostic value of TyG in actual clinical practice and offer a stronger basis for clinical decision-making.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114931"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145881268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound assessment of the perineal body: A scoping review 会阴体的超声评估:范围审查
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-20 Epub Date: 2025-12-22 DOI: 10.1016/j.ejogrb.2025.114904
Ivo Vukasović , Držislav Kalafatić , Maja Banović , Vladimir Banović

Introduction

The perineal body (PB) is a pyramidal fibromuscular structure located in the anterior part of the perineum, between the rectum and the vagina. It serves as a crucial component of the pelvic floor support system, particularly at levels II and III. Current understanding of pelvic floor anatomy is largely derived from cadaveric dissection and magnetic resonance imaging (MRI). However, ultrasound offers a promising alternative due to its ability to provide dynamic, non-invasive assessment, along with broad availability and cost-effectiveness. Importantly, ultrasound has the potential to reveal new insights into the anatomy of the perineal body and its functional role in both the static and dynamic support of the female pelvic floor.

Material and methods

This review followed the PRISMA-ScR guidelines. A comprehensive literature search was conducted in MEDLINE, Scopus, Web of Science, and grey literature sources. Eligible studies included English-language publications involving ultrasound visualization or measurement of the PB in women. Data extraction and screening were conducted independently by two reviewers, with discrepancies resolved through consensus. Data extraction encompassed a comprehensive set of variables, including study number, study design, total sample size, subgroup sample sizes, ultrasound approach, probe type, parameters measured, imaging position, and main findings.

Results

A total of 22 studies were included in the scoping review, with publications ranging from 1997 to 2025. The majority of studies were observational, and sample sizes varied from 22 to 1340 (mean 154) participants. In most studies published before 2012, endoanal ultrasound (EAUS) was the most commonly used modality. With advances in transvaginal ultrasound technology and the introduction of transperineal ultrasound, detecting and measuring the perineal body has become more accessible and precise. The perineal body can now be measured in three dimensions—depth, height, and width—rather than relying solely on the traditional measurement of perineal body thickness.

Conclusions

In conclusion, the perineal body is an important anatomical structure that can be clearly visualized and measured using ultrasound; however, significant heterogeneity in imaging approaches, probe types, and anatomical definitions underscores the need for standardized methodologies to improve reproducibility and support future clinical application in the diagnosis and management of pelvic organ prolapse.
会阴体(PB)是位于会阴前部、直肠和阴道之间的锥体状纤维肌肉结构。它是骨盆底支撑系统的重要组成部分,特别是在II级和III级。目前对骨盆底解剖学的了解主要来自尸体解剖和磁共振成像(MRI)。然而,超声提供了一个很有前途的替代方案,因为它能够提供动态的、无创的评估,以及广泛的可用性和成本效益。重要的是,超声有可能揭示会阴体的解剖结构及其在女性骨盆底的静态和动态支撑中的功能作用。材料和方法本综述遵循PRISMA-ScR指南。在MEDLINE、Scopus、Web of Science和灰色文献资源中进行了全面的文献检索。符合条件的研究包括涉及超声可视化或女性PB测量的英文出版物。数据的提取和筛选由两位审稿人独立进行,差异通过共识解决。数据提取包括一组综合变量,包括研究数量、研究设计、总样本量、亚组样本量、超声入路、探头类型、测量参数、成像位置和主要发现。结果共纳入22项研究,发表文献范围从1997年到2025年。大多数研究是观察性的,样本量从22到1340(平均154)名参与者不等。在2012年之前发表的大多数研究中,肛管超声(EAUS)是最常用的方式。随着经阴道超声技术的进步和经会阴超声的引入,会阴体的检测和测量变得更加方便和精确。会阴体现在可以用三维测量——深度、高度和宽度——而不是仅仅依靠传统的会阴体厚度测量。结论会阴体是超声能清晰显示和测量的重要解剖结构;然而,成像方法、探头类型和解剖定义的显著异质性强调了标准化方法的必要性,以提高可重复性,并支持未来盆腔器官脱垂诊断和治疗的临床应用。
{"title":"Ultrasound assessment of the perineal body: A scoping review","authors":"Ivo Vukasović ,&nbsp;Držislav Kalafatić ,&nbsp;Maja Banović ,&nbsp;Vladimir Banović","doi":"10.1016/j.ejogrb.2025.114904","DOIUrl":"10.1016/j.ejogrb.2025.114904","url":null,"abstract":"<div><h3>Introduction</h3><div>The perineal body (PB) is a pyramidal fibromuscular structure located in the anterior part of the perineum, between the rectum and the vagina. It serves as a crucial component of the pelvic floor support system, particularly at levels II and III. Current understanding of pelvic floor anatomy is largely derived from cadaveric dissection and magnetic resonance imaging (MRI). However, ultrasound offers a promising alternative due to its ability to provide dynamic, non-invasive assessment, along with broad availability and cost-effectiveness. Importantly, ultrasound has the potential to reveal new insights into the anatomy of the perineal body and its functional role in both the static and dynamic support of the female pelvic floor.</div></div><div><h3>Material and methods</h3><div>This review followed the PRISMA-ScR guidelines. A comprehensive literature search was conducted in MEDLINE, Scopus, Web of Science, and grey literature sources. Eligible studies included English-language publications involving ultrasound visualization or measurement of the PB in women. Data extraction and screening were conducted independently by two reviewers, with discrepancies resolved through consensus. Data extraction encompassed a comprehensive set of variables, including study number, study design, total sample size, subgroup sample sizes, ultrasound approach, probe type, parameters measured, imaging position, and main findings.</div></div><div><h3>Results</h3><div>A total of 22 studies were included in the scoping review, with publications ranging from 1997 to 2025. The majority of studies were observational, and sample sizes varied from 22 to 1340 (mean 154) participants. In most studies published before 2012, endoanal ultrasound (EAUS) was the most commonly used modality. With advances in transvaginal ultrasound technology and the introduction of transperineal ultrasound, detecting and measuring the perineal body has become more accessible and precise. The perineal body can now be measured in three dimensions—depth, height, and width—rather than relying solely on the traditional measurement of perineal body thickness.</div></div><div><h3>Conclusions</h3><div>In conclusion, the perineal body is an important anatomical structure that can be clearly visualized and measured using ultrasound; however, significant heterogeneity in imaging approaches, probe types, and anatomical definitions underscores the need for standardized methodologies to improve reproducibility and support future clinical application in the diagnosis and management of pelvic organ prolapse.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114904"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145838153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Confirming age before MTP in minors: reconciling POCSO mandates with adolescent reproductive rights 未成年人MTP前确认年龄:协调POCSO任务与青少年生殖权利
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-20 Epub Date: 2025-12-25 DOI: 10.1016/j.ejogrb.2025.114920
Pragnesh Parmar , Gunvanti Rathod
{"title":"Confirming age before MTP in minors: reconciling POCSO mandates with adolescent reproductive rights","authors":"Pragnesh Parmar ,&nbsp;Gunvanti Rathod","doi":"10.1016/j.ejogrb.2025.114920","DOIUrl":"10.1016/j.ejogrb.2025.114920","url":null,"abstract":"","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114920"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145838112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European journal of obstetrics, gynecology, and reproductive biology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1